CTIS2023-509156-34-02进行中(未招募)1 期
VALIDGFR; method VALIDation and evaluation of non-radioactive methods tomeasure Glomerular Filtration Rate
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 208
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+(—)
- 性别
- All
入选标准
- •Scheduled to undergo a kidney function measurement test as part of standard care, Age = 18 years, Written informed consent
排除标准
- •History of hypersensitivity to iodinated contrast media or one of the excipients in the formulation of iohexol (trometamol, sodium calcium edetate, hydrochloric acid)., Subjects with (suspected or known) thyrotoxicosis., Pregnant women and women of child-bearing potential who are not using reliable contraception, Patients who are unlikely to comply to the trial’s procedure (non-compliance)
研究者
相似试验
尚未招募
Unknown
Test of an evaluation method to measure blood hemoglobin concentration without harming the bodyot applicableJPRN-UMIN000051091Kao Corporation50
招募中
不适用
Validation of the validity and reliability of the Japanese version of the Oldenburg Burnout Inventory Medical Student version (OLBI-MS)burnoutJPRN-UMIN000048572agoya City University Graduate School of Medical Sciences160
已完成
不适用
Validation of "Clinical evaluation methods for new antibacterial drugs to treat respiratory infections" (second version)Community-acquired bacterial pneumoniaJPRN-UMIN000004831agasaki evaluation organization for clinical interventions75
招募中
不适用
Development and validation of the epidemiological diagnostic instrument for Temporomandibular DysfunctionsTemporomandibular Joint DisordersTemporomandibular Joint Dysfunction SyndromeFacial PainC05.500.607.221.897RBR-8dgwp2nDepartamento de Odontologia, Universidade Federal do Rio Grande do Norte
尚未招募
不适用
The establishment of evaluating method for general fatigue and the investigation of Kampo-medicine, Jyu-zen-ho-eki-tou, on general fatigue induced by cisplatirological patients with urothelial carcinoma, who will receive chemotherapy using cisplatinJPRN-UMIN000015799Shinshu university hospital50
